Trending Topic

Motor neuron synapses with muscle fiber via electrical impulse transmission and neurotransmitter release, forming neuromuscular junctions , motor neuron, neuroscience
15 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder of upper and lower motor neurons that results in progressive motor impairment. ALS is the most common disease of motor neurons with an annual incidence of approximately 1.7–2.5 per 100,000 people. It is a terminal condition with a typical life expectancy of 2–5 years from symptom onset. […]

US NEUROLOGY – VOLUME 11 ISSUE 1 – SPRING 2015

Select a Section…

Welcome to the latest edition of US Neurology, which features a diverse range of articles covering several therapeutic areas. This edition begins with two articles on multiple sclerosis (MS): Bethoux and Dapul review the use of functional electrical stimulation for foot drop—highlighting its potential to complement other strategies to enhance mobility and safety in suitable […]

2

Multiple Sclerosis

thumbnail-7.png

Multiple sclerosis (MS) is a chronic, progressive disease of the central nervous system, believed to be caused by an autoimmune process, and resulting in demyelination and axonal loss in the brain, spinal cord, and optic nerves. MS affects approximately 400,000 individuals in the US alone and 2.5 million people worldwide. A decline in neurologic function, […]

thumbnail-12.png

Demyelinating disorders of the central nervous system (CNS) occur in approximately 1/100,000 children. About one-fifth of these children will eventually receive a diagnosis of multiple sclerosis (MS).1 These cases constitute approximately 2–5 % of all cases of MS.2 Of these children, up to three-quarters will experience cognitive decline, depression, and/or fatigue, and irreversible motor disability […]

3

Parkinson’s Disease

Issaccson.png

Parkinson’s disease (PD) is a progressive neurodegenerative synucleinopathy. Clinical diagnosis is based on the presence of motor symptoms, including bradykinesia, rigidity, rest tremor, and postural instability.1 Although the cause of PD is still unknown, the severe nigro-striatal dopamine loss provides the basis for dopaminergic treatment of motor symptoms. Nonmotor symptoms are also prominent, probably reflecting […]

Parisa.png

Parkinson’s disease (PD) is the second most common neurodegenerative disorders worldwide1 and is a chronic and progressive condition,2,3 which affects 1 % of the older population (>60 years of age).4 Over the years, major research has been focused on the motor impairments in PD, which has contributed to the development of symptomatic treatments for these […]

4

Pain

Irving.png

Post-herpetic neuralgia (PHN), a neuropathic pain disorder resulting from nerve fiber damage following herpes zoster (HZ) infection, is caused by reactivation of the varicella zoster virus (VZV).1–3 VZV reactivation leads to the symptom complex commonly known as shingles.4 PHN is defined as VZV-associated pain persisting for more than 3 months after resolution of a VZV […]

5

Neuromuscular Disorders

Walgreens.png

Patient-reported Outcome Measures The primary aim of treating disease is to give patients freedom from symptoms, disability and side effects, and the freedom to function. Objectively and reliably measuring disability and quality of life (QoL) can be challenging but using patient-reported outcome measures (PROMs), in addition to clinical examination by physician, has proved a valuable […]

6

Chronic Inflammatory Demyelinating Polyneuropathy

Dubow.png

Diabetes mellitus (DM) is a leading cause of peripheral neuropathy.1–3 A distal symmetric sensorimotor polyneuropathy (DSP), is the most common manifestation,4 and is considered to be mainly due to axonal degeneration and progressive loss of nerve fibers.5–7 However, focal and multifocal peripheral nerve lesions, comprising cranial, thoracoabdominal, and limb nerve lesions, including proximal lumbosacral radiculoplexus […]

7

Amyotrophic Lateral Sclerosis

Surizu.png

Fasciculation, which is observed in various peripheral motor neuron disorders, is most frequently found in nonprogressive benign fasciculation syndrome (BFS).1 Patients with BFS never exhibit muscle atrophy or pathologic weakness and not all such patients visit hospitals; therefore, the prevalence and characteristics of BFS still need to be established. However, among the progressive disorders involving […]

8

Epilepsy

Wesley.png

Seizures, paroxysmal neurological symptoms caused by episodic and pathologic neuronal discharging, have myriad associated signs/ symptoms that are dependent upon its anatomical origin and subsequent spread. The underlying causes of “epilepsy” (recurrent seizures) are many and include genetic factors, congenital and/or developmental anomalies, infections, trauma, and tumors. The incidence of epilepsy is approximately 1 %. […]

9

Stroke

Kuzniecky.png

The nation’s first Mobile Stroke Unit (MSU) was launched in February, 2014 by James Grotta, MD, and colleagues at the Texas Medical Center in Houston. The concept, pioneered by Marie Curie when she loaded an X-ray machine onto an ambulance during World War I, is logical: to take emergency care to the patient in order […]

Motl.png

Acute endovascular stroke therapy is designed to restore perfusion for patients with large vessel occlusions (LVOs) to hopefully minimize any eventual disability. This subgroup of severely affected stroke patients comprise only a minority of the 800,000 strokes that occur annually in the US.1 But this same group consumes a disproportionately large share of stroke care […]

10

Headache

Headache-1.png

Monoclonal antibody (mAb) treatment has revolutionized the approach to many diseases and represents a fast-growing area of drug development.1,2 They are composed of immunoglobulin G (IgG) isotypes, divided into four subclasses.3 In 1986, the US Food and Drug Administration (FDA) approved muromonab-CD3, the first mouse-derived therapeutic mAb indicated for transplant rejection.4 Human or “fully human” […]

Naegel.png

The last major breakthrough in the treatment of migraine and cluster headache (CH) began in the 1980s with the development of subcutaneous sumatriptan, which was introduced to the US market in 1993. Sumatriptan was life-changing for many individuals with migraine, and began what was hailed as the “triptan revolution.” The “revolution” was followed by the […]

11
View All Issues

touchREVIEWS in Neurology is a peer-reviewed, free-to-access, bi-annual neurology journal comprising review articles, case reports, practice guides, theoretical discussions, and original research. It features balanced and comprehensive articles written by leading authorities, addressing the most important and salient developments in the field of neurology.

Close Popup